Cases filed in the Third Circuit Courts
Cases 21 - 30 of 365
MCNALL v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv21327
Plaintiff: MARK MCNALL
Defendant: AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al. We have downloadable decisions or orders for this case
as 1:2019cv01727
Counter Defendant: Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant: MSN Laboratories Private Limited, Alkem Laboratories Limited, Hetero USA Inc. and others
Plaintiff: Eden Biodesign, LLC.
Defendant: Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
WILLIAMS v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv20392
Plaintiff: RICHARD WILLIAMS
Defendant: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, HUAHAI U.S. INC., SOLCO HEALTHCARE U.S., LLC and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DAVIDSON v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv11870
Plaintiff: TOM DAVIDSON
Defendant: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., SOLCO HEALTHCARE U.S., LLC and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BERKOVSKI et al v. HETERO DRUGS LTD. et al
as 1:2023cv04153
Plaintiff: IGOR BERKOVSKI and YEVGENIYA BERKOVSKI
Defendant: HETERO DRUGS LTD., HETERO LABS LTD, CAMBER PHARMACEUTICALS INC. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BLANCHARD et al v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv04108
Plaintiff: PAUL BLANCHARD and TERRY BLANCHARD
Defendant: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., SOLCO HEALTHCARE U.S., LLC., WAL-MART, INC. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Pfizer Inc. et al v. Annora Pharma Private Limited et al
as 1:2023cv00634
Plaintiff: Pfizer Inc., C.P. Pharmaceuticals International C.V., PF Prism C.V. and others
Defendant: Annora Pharma Private Limited and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ILER v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv03746
Plaintiff: JOAN ILER
Defendant: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, HUAHAI U.S. INC., SOLCO HEALTHCARE U.S., LLC and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
CMP Development, LLC v. Hetero USA Inc. et al
as 1:2023cv00747
Plaintiff: CMP Development, LLC
Defendant: Hetero USA Inc., Hetero Labs Limited Unit - III and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
LAMB v. HETERO DRUGS, LTD. et al
as 1:2023cv03700
Plaintiff: VICKI LAMB
Defendant: HETERO DRUGS, LTD., HETERO LABS, LTD., VIVIMED LIFE SCIENCES PVT. LTD. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?